(19)
(11) EP 3 935 167 A2

(12)

(88) Date of publication A3:
29.10.2020

(43) Date of publication:
12.01.2022 Bulletin 2022/02

(21) Application number: 20770560.9

(22) Date of filing: 09.03.2020
(51) International Patent Classification (IPC): 
C12N 15/11(2006.01)
A61K 31/7088(2006.01)
C12N 15/113(2010.01)
A61K 47/54(2017.01)
(52) Cooperative Patent Classification (CPC):
C12N 2310/14; C12N 15/113; C12N 2310/11; C12N 2310/3519
(86) International application number:
PCT/US2020/021652
(87) International publication number:
WO 2020/185651 (17.09.2020 Gazette 2020/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.03.2019 US 201962815647 P

(71) Applicants:
  • Rutgers, the State University of New Jersey
    New Brunswick, NJ 08901 (US)
  • Silagene, Inc.
    Hillsborough, NJ 08844 (US)

(72) Inventors:
  • GUNDERSON, Samuel, Ian
    Piscataway, NJ 08854 (US)
  • GORACZNIAK, Rafal
    Hillsborough, NJ 08844 (US)

(74) Representative: Hobson, David James et al
Mathys & Squire The Shard 32 London Bridge Street
London SE1 9SG
London SE1 9SG (GB)

   


(54) COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE